Julien Capers
Consigliere Generale presso VERA THERAPEUTICS, INC.
Posizioni attive di Julien Capers
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VERA THERAPEUTICS, INC. | Consigliere Generale | 01/09/2022 | - |
Storia della carriera di Julien Capers
Precedenti posizioni note di Julien Capers
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZOGENIX, INC. | Corporate Officer/Principal | - | - |
Formazione di Julien Capers
| Stanford University | Undergraduate Degree |
| UC Davis School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| General Counsel | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VERA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Julien Capers
- Esperienza